Institutional investors purchased a net $14.2 million shares of GSK during the quarter ended December 2014 and now own 10.56% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WADDELL & REED INVESTMENT MANAGE... Bought 5.3 Million shares of GlaxoSmithKline
MICHIGAN DEPARTMENT OF TREASURY ... Bought 2.7 Million shares of GlaxoSmithKline
JANE STREET CAPITAL LLC Bought 1.8 Million shares of GlaxoSmithKline